VAXCYTE INC's ticker is PCVX and the CUSIP is 92243G108. A total of 201 filers reported holding VAXCYTE INC in Q3 2023. The put-call ratio across all filers is 0.83 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,511,836 | +3.8% | 49,271 | +1.7% | 0.02% | +11.1% |
| Q2 2023 | $2,419,343 | +71.8% | 48,445 | +28.9% | 0.02% | +80.0% |
| Q1 2023 | $1,408,348 | -21.8% | 37,576 | 0.0% | 0.01% | -28.6% |
| Q4 2022 | $1,801,769 | +172.8% | 37,576 | +36.5% | 0.01% | +133.3% |
| Q3 2022 | $660,552 | +10.3% | 27,523 | 0.0% | 0.01% | +20.0% |
| Q2 2022 | $598,900 | +4.7% | 27,523 | +16.2% | 0.01% | +25.0% |
| Q1 2022 | $572,089 | +60.9% | 23,689 | +58.5% | 0.00% | +33.3% |
| Q4 2021 | $355,565 | -6.2% | 14,946 | 0.0% | 0.00% | -25.0% |
| Q3 2021 | $379,180 | +12.7% | 14,946 | 0.0% | 0.00% | +33.3% |
| Q2 2021 | $336,434 | +45.5% | 14,946 | +27.7% | 0.00% | +50.0% |
| Q1 2021 | $231,233 | +10.7% | 11,708 | +48.9% | 0.00% | 0.0% |
| Q4 2020 | $208,893 | -46.2% | 7,862 | 0.0% | 0.00% | -50.0% |
| Q3 2020 | $388,226 | – | 7,862 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Abingworth LLP | 4,168,718 | $99,174,000 | 24.03% |
| Medicxi Ventures Management (Jersey) Ltd | 1,887,478 | $44,903,000 | 11.24% |
| Pivotal bioVenture Partners Investment Advisor LLC | 1,111,485 | $26,442,000 | 11.06% |
| FRAZIER MANAGEMENT LLC | 2,309,554 | $54,944,000 | 4.23% |
| Kynam Capital Management, LP | 211,483 | $5,031,000 | 2.69% |
| GREAT POINT PARTNERS LLC | 500,000 | $11,895,000 | 2.64% |
| Ghost Tree Capital, LLC | 250,000 | $5,948,000 | 2.13% |
| RA Capital Management | 4,240,464 | $100,881,000 | 1.78% |
| Opaleye Management Inc. | 315,800 | $7,513,000 | 1.59% |
| Ikarian Capital, LLC | 295,111 | $7,021,000 | 1.05% |